Lynx Revenues Down, Net Loss Up

Feb 26, 2003

NEW YORK, Feb. 26 -- Lynx Therapeutics recorded a net loss of $3 million for the fourth quarter ending Dec. 31, the company reported today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Exact Sciences Q2 Revenues Up 172 Percent
Late-Onset Preeclampsia Markers Proposed From Proteomic Study
Genetic Predisposition to High Blood Calcium Linked to Increased Heart Disease Risk
NIH Selects Community Partners to Promote Precision Medicine Initiative
Roche Includes Cobas HIV-1/HIV-2 Test in Global Access Program
Waters Q2 Revenues Grow 4 Percent

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

This Week in PNAS

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

'Lifestyle Zone'

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

Main menu